Medy-Tox Inc. | Ownership
Companies that own Medy-Tox Inc.
Mirae Asset Global Investments Co., Ltd.
282,577
5%
-18,024
1.4%
01/04/2017
Wasatch Advisors, Inc.
139,499
2.47%
-26,485
0.55%
03/31/2018
Schroder Investment Management Ltd.
132,381
2.34%
1,261
0.05%
07/31/2018
The Vanguard Group, Inc.
103,545
1.83%
2,010
0%
07/31/2018
BlackRock Fund Advisors
100,764
1.78%
28
0%
09/06/2018
Templeton Asset Management Ltd. (Hong Kong)
88,035
1.56%
-906
0.32%
06/30/2018
Sands Capital Management LLC
64,171
1.12%
-1,295
0.1%
06/30/2018
Norges Bank Investment Management
63,887
1.12%
-28,135
0.01%
12/31/2017
Templeton Asset Management Ltd.
63,592
1.12%
0
1.29%
06/30/2018
OppenheimerFunds, Inc.
47,730
0.84%
3,780
0.02%
03/31/2018
| Address |
78 Gangni 1-gil
Cheongju-si NC 28126
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.medy-tox.co.kr |
| Updated |
09/14/2018 |
| Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and antitoxin therapeutics. The company was founded on May 2, 2000 and is headquartered in Cheongju-si, South Korea. |
